Kimelman & Baird’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.3K Hold
600
﹤0.01% 166
2025
Q4
$54K Hold
600
﹤0.01% 166
2025
Q3
$59.1K Hold
600
﹤0.01% 171
2025
Q2
$54.7K Hold
600
﹤0.01% 181
2025
Q1
$67.9K Hold
600
0.01% 167
2024
Q4
$63.4K Hold
600
0.01% 172
2024
Q3
$64.8K Hold
600
0.01% 173
2024
Q2
$65.1K Buy
+600
New +$70.7K 0.01% 171
2021
Q2
$418K Buy
+2,678
New +$434K 0.04% 87
2019
Q3
$357K Hold
2,678
0.05% 80
2019
Q2
$306K Hold
2,678
0.04% 87
2019
Q1
$332K Hold
2,678
0.05% 85
2018
Q4
$270K Hold
2,678
0.04% 88
2018
Q3
$342K Hold
2,678
0.04% 82
2018
Q2
$290K Buy
+2,678
New +$291K 0.04% 92
2017
Q4
$314K Hold
2,678
0.04% 92
2017
Q3
$304K Hold
2,678
0.05% 96
2017
Q2
$334K Hold
2,678
0.05% 97
2017
Q1
$317K Hold
2,678
0.05% 96
2016
Q4
$268K Hold
2,678
0.04% 97
2016
Q3
$338K Hold
2,678
0.06% 79
2016
Q2
$313K Hold
2,678
0.06% 81
2016
Q1
$277K Sell
2,678
-94
-3% -$9.09K 0.05% 92
2015
Q4
$276K Buy
+2,772
New +$271K 0.05% 90
2015
Q2
$294K Hold
2,772
0.05% 97
2015
Q1
$316K Hold
2,772
0.06% 93
2014
Q4
$305K Hold
2,772
0.06% 97
2014
Q3
$271K Hold
2,772
0.05% 98
2014
Q2
$279K Hold
2,772
0.05% 99
2014
Q1
$255K Buy
2,772
+94
+4% +$8.66K 0.05% 94
2013
Q4
$242K Buy
+2,678
New +$232K 0.05% 92

Other funds holding ZBH

Kimelman & Baird's ZBH Position: Q1 2026 in Review

Kimelman & Baird held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 600 shares worth $54.3K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Kimelman & Baird first reported a position in ZBH in Q4 2013 and has held it in 31 quarters since. The position peaked at $418K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Kimelman & Baird held 600 shares of Zimmer Biomet worth $54.3K as of Q1 2026.
  • Kimelman & Baird left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Kimelman & Baird's portfolio in Q1 2026, its #166 holding.
  • Kimelman & Baird first reported a position in Zimmer Biomet in Q4 2013 and has held it in 31 quarters since.
  • Kimelman & Baird's Zimmer Biomet position peaked at $418K in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.